Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides

NCT00973271 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Did not continue with development of DCCR in Very High Triglycerides

Conditions

Hypertriglyceridemia

Interventions

DRUG: 290 mg DCCR
DRUG: 435 mg DCCR
DRUG: 135 mg fenofibric acid
DRUG: Placebo
DRUG: atorvastatin

Sponsor

Essentialis, Inc.